3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
23
Observational
1
Sponsor
Cancer Type
Myeloid
1
Lymphoid
1
Conditions
Multiple Myeloma
7
Recurrence
4
Lymphoma, Large B-Cell, Diffuse
4
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
2
Lymphoma
2
Tumor Lysis Syndrome
1
Thromboembolism
1
Teratogenesis
1
Sleepiness
1
Seizures
1
Renal Insufficiency
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Peripheral Nervous System Diseases
1
Neoplasms, Second Primary
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Myelodysplastic Syndromes
1
Lung Diseases, Interstitial
1
Infections
1
Hypothyroidism
1
Hypotension, Orthostatic
1
Hypersensitivity
1
Hemorrhage
1
Heart Failure
1
Fatigue
1
Dizziness
1
Digestive System Diseases
1
Coronary Artery Disease
1
Confusion
1
Interventions
Flow Cytometry
7
Blood Specimen Collection
5
Surveys and Questionnaires
4
Psychiatric Rehabilitation
4
Polymerase Chain Reaction
4
Cytogenetic Analysis
4
Biopsy
4
In Situ Hybridization, Fluorescence
3
fludarabine
2
Microarray Analysis
2
Influenza Vaccines
2
Immunoenzyme Techniques
2
Gene Expression Profiling
2
Cyclophosphamide
2
Bone Marrow Transplantation
2
luspatercept
1
Watchful Waiting
1
Vision, Ocular
1
Therapeutics
1
Respiratory Physiological Phenomena
1
Radioimmunodetection
1
Peripheral Blood Stem Cell Transplantation
1
Observation
1
Molecular Diagnostic Techniques
1
Mesna
1
Mental Status and Dementia Tests
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
Interviews as Topic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Myelodysplastic Syndromes
×
Lenalidomide
×
Clear all
NCT04036448
2025-03-11
RevlimidPMS
Celgene
Completed
28 enrolled